Clostridium difficile

The C. difficile bacterium is responsible for the most common form of hospital-acquired diarrhea and antibiotic-associated colitis. It is highly infectious and a significant danger to the health of immunocompromised or elderly patients. The infection can be life-threatening when not caught in time to allow for appropriate therapy. In U.S. hospitals alone, current annual spending is estimated at $40 million in testing aimed at diagnosing C. difficile to provide appropriate therapy and control the spread of the disease.

Searching for Results

Alere Brands

for Clostridium difficile:

All Wellness Solutions

In order to provide clients with state of the art care, Alere has developed Wellness Solutions, which combine the latest in technology, services, and research in order to treat clients holistically. These solutions are listed below.